Quipot, Alim K.
HRN: 21 84 60 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/25/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/25/2023
03/04/2023
INTRAVENOUS
500 Mg
Q8h
Acute Pyelonephritis, Cannot Rule Out Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes